$ANAB

$49.63 +$0.86 (1.76%) Close

$ANAB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ANAB Management Team

Mr. John Orwin

Non-Executive Independent Chairman of the Board

Age 63

Compensation $456.7K USD

Sex Male

Mr. Daniel Faga

President

Chief Executive Officer

Director

Age 45

Compensation $13.63M USD

Sex Male

Mr. Dennis Mulroy

Chief Financial Officer

Age 70

Compensation $3.239M USD

Sex Male

Dr. Paul Lizzul

Chief Medical Officer

Age 50

Compensation $4.584M USD

Sex Male

Mr. Eric Loumeau

Chief Legal Officer

Age 62

Compensation $2.258M USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. John Orwin Non-Executive Independent Chairman of the Board	63	$456.7K USD	Male
Mr. Daniel Faga President Chief Executive Officer Director	45	$13.63M USD	Male
Mr. Dennis Mulroy Chief Financial Officer	70	$3.239M USD	Male
Dr. Paul Lizzul Chief Medical Officer	50	$4.584M USD	Male
Mr. Eric Loumeau Chief Legal Officer	62	$2.258M USD	Male

Board of Directors

From the proxy statement filed Jun 29, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

5.3 years

from year joined

CEO also chairs the board

John Orwin

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Hollings Renton	79	2015 11 years	Independent	nominating and corporate governance committee · Chair	None stated	$320,233
John P. Schmid	63	2015 11 years	Independent	audit committee · Chair	Design Therapeutics Inc.	$336,983
Daniel Faga CEO	46	2021 5 years	Not independent	None stated	None stated	Paid as CEO
John Orwin Board chair	61	Not stated	Independent	compensation committee · Chair	First Tracks Biotherapeutics, Inc.	$370,233
Oleg Nodelman	49	2021 5 years	Independent	nominating and corporate governance committee	Galapagos NV, Zymeworks	Not stated
Susannah Gray	66	2026 0 years	Independent	audit committee	Maravai LifeSciences Holdings, Inc.	Not stated
Owen Hughes	51	2026 0 years	Independent	None stated	C4 Therapeutics	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jun 29, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$ANAB Management Team

Mr. John Orwin

Mr. Daniel Faga

Mr. Dennis Mulroy

Dr. Paul Lizzul

Mr. Eric Loumeau

Board of Directors

Related-party transactions

No related-party transactions disclosed